期刊文献+

高危型HPV/TCT检测在宫颈疾病筛查中的临床价值 被引量:1

Clinic value of combination of high risk HPV test and ThinPrep liquid-based cytology in cervical screening
原文传递
导出
摘要 目的:探讨高危型HPV(HR-HPV)检测联合宫颈液基细胞学(TCT)检查(HR-HPV/TCT)在宫颈疾病筛查中的临床价值。方法:回顾性分析2008-01-2011-01来我院就诊的自愿接受HR-HPV/TCT检测的患者2140例。对TCT异常和TCT阴性而HR-HPV阳性的患者386例进行阴道镜加活检检查。结果:TCT异常者327例,ASCUS(意义不明宫颈不典型鳞状上皮细胞)196例,LSIL(低度宫颈上皮内病变)93例,HSIL(高度上皮内病变)38例。病理报告炎症156例,宫颈癌前病变(CIN)160例(其中CINⅡ级和Ⅲ级共60例),宫颈癌11例。HR-HPV检出率随宫颈病变级别的增高而上升(P<0.005)。TCT阴性而HR-HPV阳性的患者59例,病理报告炎症29例,CIN27例(CINⅡ级和Ⅲ级共12例),宫颈癌3例。结论:HR-HPV/TCT检测可有效检出宫颈CIN和宫颈癌,减少漏诊率。 Objective:To discussion clinic value of high risk HPV (HR-HPV) testing combined with cervical liquid-based cytology (TCT) in cervical screening. Method:A total of 2 140 patients were tested for HR-HPV de- tection combined with TCT check from January 2008 to January 2011. Three hundred and eighty-six cases of ab- normal and TCT TCT negative HR-HPV positive patients, colposcopy with biopsy examination. Result.-TCT ab- normal in 327 cases, 196 cases of ASCUS. (Of undetermined significance cervical atypical squamous cells), LSIL (low-grade cervical intraepithelial neoplasia) 93 cases of HSIL (high intra-epithelial lesions of 38 patients). Patho- logical report on inflammation in 156 cases, CIN160 cases (the which CIN ]I level and Class Ill 60 cases), 11 ca- ses of cervical cancer. The HR-HPV detection rate increased with the increased level of cervical lesions (P〈0. 005). TCT negative HR-HPV-positive patients with 59 cases of inflammation of pathology reports of 29 cases, the CIN27 cases (12 cases CIN 11 level and class Ⅲ ), three cases of cervical cancer. Conclusion.. HR-HPV/TCT detection can be effectively detected in cervical CIN and cervical cancer, reduce the rate of misdiagnosis.
作者 李旺群
出处 《临床急诊杂志》 CAS 2012年第4期254-255,258,共3页 Journal of Clinical Emergency
关键词 HR-HPV检测 宫颈不典型鳞状细胞 二代杂交捕获 HR-HPV detection atypical squamous cell of undetermined significance hybrid capture II
  • 相关文献

参考文献8

  • 1FALLANI M G, PENNA C, FAMBRINI M, et al. Cervical cytologic reports of ASCUS and LSIL. Cyto- histological correlation and implication for manage- ment[J]. Minerva Ginecol, 2002,54 : 263- 269.
  • 2WRIGHT T C J R,COX J T,MASSAD L S, et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities[J]. JA- MA,2002,287 : 2120- 2129.
  • 3CRABTREE D, UNKRAUT A, COZENS D, et al. Role for HPV testing in ASCUS:a cytologic-histo- logic correlation [J ]. Diagn Cytopathol, 2002, 27: 382 - 386.
  • 4SCHLECHT N F, TRERISAN A, DUARTE-FRAN- CO E,et al. Viral load as a predictor of risk of cervical intraepithelial neoplasia[J]. Int cancer, 2003,103 : 519 -524.
  • 5MUNOZ N,BOSCH F X. Epidemiologic elassifieation of human papillomavirus types associated with cervical caneer[J]. N Engl J Med,2003,348:518-527.
  • 6MONNIER-BENOIT, MAUNV F, R1ETHMULLER D,et al. Immunohistochemical analysis of CD4 + and CD8+ T-cell subsets in high risk human papilloma- virus-associated pre-malignant and malignant lesions of the uterine cervix[J]. Gynecol Oncol, 2006,102 : 22 -31.
  • 7INOUE M, SAKAQUCHI J, SASAQAWA T, et al. The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Jap- anese population[J]. Int J Gynecol Cancer, 2006,16 : 1007-1013.
  • 8钱德英,岑坚敏,王丁,曾仁海,林爱华,舒焰红,洪淡华,黄志宏.高危型人乳头状瘤病毒DNA检测与细胞学联合检查对子宫颈癌前病变筛查的研究[J].中华妇产科杂志,2006,41(1):34-37. 被引量:168

二级参考文献15

  • 1Syrjanen S,Shabalova IP,Petrovichev N,et al.Human papillomavirus testing and conventional Pap smear cytology as optional screening tools of women at different risks for cervical cancer in Countries of the former Soviet Union.J Low Genit Tract Dis,2002,6:97-110.
  • 2Bosch FX,Manos MM,Munoz N,et al.Prevalence of human papillomavirus in cervical cancer:a worldwide perspective.International biological study on cervical cancer (IBSCC) Study Group.J Natl Cancer Inst,1995,87:796-802.
  • 3Vizcaino AP,Moreno V,Bosch FX,et al.International trends in incidence of cervical cancer:Ⅱ.Squamous-cell carcinoma.Int J Cancer,2000,86:429-435.
  • 4Munoz N,Bosch FX,de Sanjose S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer.N Engl J Med,2003,348:518-527.
  • 5Clavel C,Masure M,Bory JP,et al.Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions:a study of 7932 women.Br J Cancer,2001,84:1616-1623.
  • 6Blumenthal PD,Gaffikin L,Chirenje ZM,et al.Adjunctive testing for cervical cancer in low resource settings with visual inspection,HPV,and the Pap smear.Int J Gynaecol Obstet,2001,72:47-53.
  • 7Kuhn L,Denny L,Pollack A,et al.Human papillomavirus DNA testing for cervical cancer screening in low-resource settings.J Natl Cancer Inst,2000,92:818-825.
  • 8Saslow D,Runowicz CD,Solomon D,et al.American cancer society guideline for the early detection of cervical neoplasia and cancer.CA Cancer J Clin,2002,52:342-362.
  • 9Sherman ME,Lorincz AT,Scott DR,et al.Baseline cytology,human papillomavirus testing,and risk for cervical neoplasia:a 10-year cohort analysis.J Natl Cancer Inst,2003,95:46-52.
  • 10Belinson J,Qiao YL,Pretorius R,et al.Shanxi province cervical cancer screening study:a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.Gynecol Oncol,2001,83:439-444.

共引文献167

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部